Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Helix BioSearch is seeking a Co-Founder or Founding Scientist to build an AI-native immunotherapy discovery platform from the ground up in collaboration with a stealth-mode biotech partner.
You will lead computational strategies for antibody/TCR design, sequence optimization and structure-function prediction, translating insights into experimental designs and shaping the platform’s technical roadmap.
Compensation: Founder Salary + meaningful equity
Helix BioSearch is partnering with a stealth-mode biotechnology company being built around an AI-native approach to the discovery and development of next-generation biologic immunotherapies. The company’s ambition is to use modern AI and machine learning as a fundamental part of the therapeutic discovery process, transforming how therapeutic proteins are designed, optimized and developed rather than simply adding computational tools to a conventional biotech workflow.
We are seeking a Co-Founder or Founding Scientist to join at a genuinely formative stage and help shape the company’s scientific and computational direction. This is a highly visible opportunity for a hands-on computational scientist who wants to go beyond applying established models – someone who wants to decide which problems should be solved, which approaches are most promising and how an AI-native discovery platform should be built.
Working closely with the founding team and experimental scientists, you will develop and apply computational approaches across antibody and/or T-cell receptor (TCR) engineering, sequence design, protein representation, structure-function prediction and optimization, translating computational insight into experimentally testable designs.
This is an opportunity to join an AI-native biotech early enough to build the roadmap rather than inherit one. You’ll play a pivotal role in defining the company’s computational platform, scientific strategy and, ultimately, its direction.
If you’re passionate about machine learning, therapeutic protein design and building an AI-first discovery platform from the ground up, we’d welcome a confidential conversation.